PETER PEKOS - Net Worth and Insider Trading
PETER PEKOS Net Worth
The estimated net worth of PETER PEKOS is at least $8,436 dollars as of 2024-11-12. PETER PEKOS is the Director of Cardiol Therapeutics Inc and owns about 3,090 shares of Cardiol Therapeutics Inc (TSX:CRDL) stock worth over $8,436. Details can be seen in PETER PEKOS's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that PETER PEKOS has not made any transactions after 2019-10-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of PETER PEKOS
PETER PEKOS Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, PETER PEKOS owns 1 companies in total, including Cardiol Therapeutics Inc (TSX:CRDL) .
Click here to see the complete history of PETER PEKOS’s form 4 insider trades.
Insider Ownership Summary of PETER PEKOS
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSX:CRDL | Cardiol Therapeutics Inc | 2019-10-17 | Director |
PETER PEKOS Latest Holdings Summary
PETER PEKOS currently owns a total of 1 stock. PETER PEKOS owns 3,090 shares of Cardiol Therapeutics Inc (TSX:CRDL) as of October 17, 2019, with a value of $8,436.
Latest Holdings of PETER PEKOS
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSX:CRDL | Cardiol Therapeutics Inc | 2019-10-17 | 3,090 | 2.73 | 8,436 |
Holding Weightings of PETER PEKOS
PETER PEKOS Form 4 Trading Tracker
According to the SEC Form 4 filings, PETER PEKOS has made a total of 0 transactions in Cardiol Therapeutics Inc (TSX:CRDL) over the past 5 years. The most-recent trade in Cardiol Therapeutics Inc is the acquisition of 3,090 shares on October 17, 2019, which cost PETER PEKOS around $10,753.
Insider Trading History of PETER PEKOS
- 1
PETER PEKOS Trading Performance
GuruFocus tracks the stock performance after each of PETER PEKOS's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by PETER PEKOS is -10.96%. GuruFocus also compares PETER PEKOS's trading performance to market benchmark return within the same time period. The performance of stocks bought by PETER PEKOS within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how PETER PEKOS's insider trading performs compared to the benchmark.
Performance of PETER PEKOS
PETER PEKOS Ownership Network
Ownership Network List of PETER PEKOS
Ownership Network Relation of PETER PEKOS
PETER PEKOS Owned Company Details
What does Cardiol Therapeutics Inc do?
Who are the key executives at Cardiol Therapeutics Inc?
PETER PEKOS is the Director of Cardiol Therapeutics Inc. Other key executives at Cardiol Therapeutics Inc include Senior Officer Guillermo Torre , Director & Senior Officer David Elsley , and Director & Senior Officer Christopher James Waddick .
Cardiol Therapeutics Inc (TSX:CRDL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cardiol Therapeutics Inc (TSX:CRDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiol Therapeutics Inc Insider Transactions
PETER PEKOS Mailing Address
Above is the net worth, insider trading, and ownership report for PETER PEKOS. Currently GuruFocus does not have mailing address information for PETER PEKOS.